ACE-031 is a soluble activin receptor type IIB (ActRIIB) fusion protein — unlike linear peptides, its mechanism involves acting as a decoy receptor that binds myostatin and related ligands before they can signal through endogenous receptors. This makes ACE-031 structurally and mechanistically distinct from other research peptides.
🧬 ACE-031 Structure and Mechanism
| Property | Value |
|---|---|
| Type | ActRIIB-Fc fusion protein |
| Target | Myostatin (GDF-8), Activin A, GDF-11 |
| Mechanism | Soluble decoy receptor (ligand trap) |
| Molecular Weight | ~25-30 kDa (glycosylated) |
🔬 Research Applications
ACE-031 is primarily used in muscle biology research to study the effects of myostatin pathway inhibition — it binds circulating myostatin before the ligand can engage the ActRIIB receptor on muscle cells. This mechanism makes it a useful tool for studying muscle hypertrophy signaling, satellite cell activation, and muscle wasting disease models.
🧪 Quality and Handling Considerations
- Purity: SDS-PAGE ≥95% required. HPLC alone may not resolve glycosylated species
- MS verification: Due to glycosylation heterogeneity, exact mass spectrometry is less definitive than for linear peptides. SDS-PAGE + Western blot provide better identity confirmation
- Storage: Lyophilized at -20°C (12+ months). Reconstituted at 2-8°C (7 days max)
- Solubility: PBS or Tris buffer recommended. Avoid pure water for reconstitution
- Avoid agitation: Fusion proteins are more susceptible to aggregation from vortexing than short peptides. Gently swirl to dissolve
⚠️ Special Considerations
ACE-031 is a recombinant protein, not a synthetic peptide — traditional peptide QC metrics (HPLC, MS) are less informative than SDS-PAGE and functional assays. Researchers should request SDS-PAGE data showing a single band at the expected molecular weight range, confirming the absence of truncated forms or aggregates.
❓ FAQ
Q: Why can’t ACE-031 purity be assessed by HPLC alone?
A: ACE-031 is a glycosylated fusion protein with heterogeneous glycan structures — it runs as a smear or broad peak on HPLC rather than a single sharp peak. SDS-PAGE with Coomassie or silver staining provides more meaningful purity information for glycosylated proteins.
Q: How should ACE-031 be stored after reconstitution?
A: Aliquot and freeze at -20°C to -80°C immediately after reconstitution. Use within 7 days if stored at 2-8°C, or within 30 days frozen. Fusion proteins are generally less stable than short peptides after reconstitution. Add 0.1% BSA as a carrier protein if concentration is below 0.1 mg/mL to prevent surface adsorption.
Q: Is ACE-031 interchangeable with other myostatin inhibitors for research?
A: No — ACE-031 (ActRIIB-Fc) binds multiple TGF-β family ligands (myostatin, activin A, GDF-11), while follistatin-based inhibitors and anti-myostatin antibodies have different selectivity profiles. Choose based on your experimental question: ACE-031 for broad pathway inhibition, selective antibodies for isolating myostatin-specific effects.